NEW
Font size
WorksheetsPHARMACOLOGY 602
Total questions: 15
Worksheet time: 15mins
_________Group of drugs is used for asthma treatment.
a) Methylxanthines
b) M-cholinoblocking agents
c) Beta 2-stimulants
d) All of above
The mechanism of methylxanthines action is
a) Inhibition of the enzyme phosphodiesterase
b) Beta2-adrenoreceptor stimulation
c) Inhibition of the production of inflammatory cytokines
d) Inhibition of M-cholinoreceptors
What is the therapeutic class that does not have anticholinergic properties?
a) Tricyclic antidepressants
b) Digitalis
c) Antiparkinsonism
d) Digestive antispasmodics
Drug used to stabilize Mast Cell?
a) Chromolyn Sodium
b)Terbutaline
c) Ipratropium
d) All
Anticholinergic Drugs used in Asthma?
a) Atropine
b) Aspirin
c) Ipratropium
d) Caffeine
Aspirin Induced Asthma controlled using?
a) Chromolyn Sodium
b) Diphenhydramine
c) Prednisolone
d) Montelukasz
Selective B2 Agonist used in Asthma?
a) Dopamine
b) Dobutamine
c) Salbutamol
d) Ephedrine
Long Acting Beta 2 Agonist is?
a) Terbutaline
b) Salbutamol
c) Salmeterol
d) none
5-Lipo-oxygenase Inhibitor?
a) Zileuton
b) Zafirlukast
c) Montelukast
d) Omalizumab
Cromokalim used in Asthma is?
a) K Channel Opener
b) K Channel Inhibitor
c) Na Channel Opener
d) Ca Channel Opener
COPD treated with?
a) Ipratropium
b) Salbutamol
c) Both
d) none
Para Amino Folate Reductase Antagonist used in Asthma?
a) Gingkolide
b) Ciclesonide
c) Formetrol
d) None
Drug treatment for asthma and COPD aim to do all of the following except:
a) Cure asthma/COPD
b) Relieve/prevent bronchoconstriction
c)Inhibit airway inflammation
d)Prevent airway remodeling
Which of the following pairs are the NON-selective beta-2-agonists?
a) Ephedrine and albuterol
b) Isoproterenol and pirbuterol
c)Ephedrine and isoproterenol
d)Salmeterol and formoterol
Beta-2-agonists, can be administered in all of the following mechanisms of action except:
a) Inhalation solutions
b) Long acting, oral agents
c)Intravenous agents
d) Inhaled dry powders
e) All of the above are routes of administration of beta-2-agonists
